The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
Key challenges to developing "trans-tumor" targeted therapies are outlined in an editorial in the New England Journal of Medicine published Thursday by Fabrice André, head of the predictive biomarkers ...
Oncology market presents opportunities driven by increasing recognition of the microbiome's role in cancer and immunotherapy. Key growth areas include microbiome-based therapeutics, diagnostics, and ...
SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...
U.S. Minimal Residual Disease Testing Market is projected to reach USD 2.37 Billion by 2035, while Europe is expected to ...
Precision oncology, largely defined by the use of molecular profiling to guide biomarker-driven therapeutic decisions, has transformed the management of multiple malignancies. 1 Biomarker discovery ...
Roche launches AXELIOS 1, a transformative next-generation sequencing platform: Basel Tuesday, June 30, 2026, 10:00 Hrs [IST] Roche, a healthcare company, announced the launch of ...
Sources matter: Learning to evaluate large language models for oncology treatment plans and changes observed by anchoring models to an oncology-specific database. (Tempus) EXT routing validation ...
Precision oncology is reshaping cancer diagnosis and treatment, with molecular diagnostics at the core. These tools guide clinical decisions across the care continuum—from early detection and tumor ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of people diagnosed with advanced cancer between 2018 and 2022 did not undergo next-generation ...
Protein variant characterization remains a central challenge in precision oncology, where understanding the functional consequences of sequence alterations can inform and drive therapeutic development ...
Zacks Investment Research on MSN
3 cancer stocks to watch as oncology innovation accelerates
An updated edition of the May 18, 2026, article. The global oncology market is evolving rapidly, fueled by rising cancer incidence, an aging population and continued scientific innovation. According ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results